The 20 Best Lymphangiectasis Doctors Near Me in Ann Arbor, MI

Geoff Barnes is a cardiologist and vascular medicine specialist at the University of Michigan Health System. He completed his undergraduate degree in biomedical engineering at Washington University in St. Louis (2003) followed by medical school at the University of Michigan (2007). He then completed an internal medicine residency (2010), chief residency in internal medicine (2011), cardiology fellowship (2014) and vascular medicine fellowship (2014) at the University of Michigan. His areas of research interest include anticoagulation, venous thromboembolism, quality improvement and shared decision making. He currently co-directs the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) a six-centered BCBSM-sponsored anticoagulation quality improvement collaborative and registry. He is leading an NIH-sponsored study to improve the coordination and care of patients on chronic anticoagulants around the time of surgical procedures. Dr. Barnes is rated as an Advanced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, Embolectomy, and Thrombectomy. Dr. Barnes is board certified in Cardiovascular Disease.

Kim Eagle is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Eagle is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Aortic Dissection, Marfan Syndrome, Thoracic Aortic Aneurysm, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI). Dr. Eagle is board certified in Internal Medicine and Cardiovascular Disease.

James Froehlich, MD, MPH, is Professor of Internal Medicine, Assistant Chair of Medicine for Quality and Innovation, Director of Vascular Medicine, Director of MCORRP (Michigan Clinical Outcomes Research and Reporting Program), and Director of Anticoagulation at the University of Michigan Medical School. He received his undergraduate degree in political philosophy from Dartmouth College in 1982, and his medical degree from Dartmouth Medical School (now the Geisel School of Medicine at Dartmouth College), in 1986. He completed a residency and chief residency in internal medicine at the New England Deaconess Hospital, Harvard Medical School, under Dr. Robert Moellering.Dr. Froehlich completed a fellowship in cardiology and vascular medicine at the University of Michigan from 1993-1996. After completing a Masters Degree in Public Health at the Harvard School of Public Health (while serving as Director of Vascular Medicine at the Beth Israel Deaconess Medical Center), he joined the faculty of the University of Massachusetts Medical Center, with a joint appointment in vascular surgery and cardiology, before returning to Michigan and his current position. Dr. Froehlich has served on the editorial boards of the Journal of Vascular Surgery, the Cardiosource Review Journal, the Journal of Thrombosis and Thrombolysis, and as an ad hoc reviewer for JAMA, NEJM, Vascular Medicine and Circulation. He is Past-President of the Society for Vascular Medicine, and has been a member of the AHA/ACC Preoperative Guidelines Committee and of the AHA Scientific Sessions Program Committee. He has published over 120 articles and 11 book chapters. He is an ardent supporter of the Boston Red Sox, the University Musical Society, and serves as on the board of directors of the Ann Arbor Symphony Orchestra. 87148673. Dr. Froehlich is rated as an Advanced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 70 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Venous Thromboembolism (VTE), Aortic Dissection, Cardiac Ablation, and Pacemaker Implantation. Dr. Froehlich is board certified in Cardiovascular Disease.

Andrea Obi is a General Surgeon and a Vascular Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Obi is rated as an Advanced provider by MediFind in the treatment of Lymphangiectasis. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Idiopathic Edema, Stasis Dermatitis and Ulcers, Venous Insufficiency, and Deep Vein Thrombosis. Dr. Obi is board certified in Vascular Surgery and Surgery.

Dr. Rodriguez is Medical Director of the Wheelchair Seating Clinic and PM&R Administrator in the Michigan Bowel Control Clinic and the Wound Care Clinic. She has been actively involved in research with the Spinal Cord Injury Model System. She has written and collaborated on several research publications and written chapters on SCI sequelae in premier journals and textbooks in PM&R. Dr. Rodriguez has been recognized for her teaching of trainees with the Silver Crutch award. She is the associate SCI fellowship program director. She also serves on the International Standards and Autonomic Standards Committees, two crucial committees of the American Spinal Injury Association that are responsible for development of any new standards documents related to SCI, continuous review and improvement of the existing ASIA documents on neurological and autonomic standards and development and oversight of the International Data Sets project. Dr. Rodriguez is rated as an Advanced provider by MediFind in the treatment of Lymphangiectasis. She is also highly rated in 43 other conditions, according to our data. Her clinical expertise encompasses Neurogenic Bowel, Paraplegia, Spasticity, and Autonomic Dysreflexia.

Dr. Sean Smith is the Medical Director of Michigan Medicine's Cancer Rehabilitation program, with a clinical emphasis on restoring function and reducing symptom burden in patients with a history of cancer. In addition to chairing the AAPM&R's Cancer Rehabilitation Physician Consortium and the multi-site research collaborative, the Cancer Rehabilitation Metrics Consortium, he serves on the editorial board of the Journal of Clinical Oncology, and is a Deputy Associate Editor for Supportive Care in Cancer. He has published numerous peer-reviewed manuscripts and has conducted educational seminars on cancer rehabilitation on three continents. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Foot Drop, Lymphedema, and Femoral Nerve Dysfunction. Dr. Smith is board certified in Physical Medicine & Rehab.

Jonathan L. Eliason, M.D., is the S. Martin Lindenauer Collegiate Professor of Vascular Surgery. Dr. Eliason received his undergraduate degree from Bethel College in St. Paul, Minnesota and his medical degree from the University of Minnesota Medical School. He then relocated to Nashville, Tennessee where he completed his General Surgery Residency at Vanderbilt University Medical Center. He became Chief Resident in the 2001-2002 academic year and proceeded into the two-year Vascular Surgery Fellowship at the University of Michigan the following year. Prior to joining the faculty at U-M, Dr. Eliason served as a Clinical Assistant Professor of Surgery at the University of Texas Health Science Center at San Antonio and as a staff surgeon for the San Antonio Military Vascular Surgery Service at Wilford Hall Medical Center and Brooke Army Medical Center. He was deployed to Balad, Iraq as a vascular surgeon in the 332nd Expeditionary Medical Group from 9/06 - 1/07 and was otherwise a member of the 859th Surgical Operations Squadron of the 59th Medical Wing at Lackland Air Force Base in Texas. He joined the faculty at the University of Michigan in the section of vascular surgery in 2007. Dr. Eliason is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Peripheral Artery Disease, Carotid Artery Surgery, and Aneurysm Repair. Dr. Eliason is board certified in Vascular Surgery and Surgery.

Frank M. Davis, MD is a faculty member in the Department of Surgery Section of Vascular Surgery, treating patients at the University of Michigan Health System and at the Veteran's Administration Medical Center. He graduated Phi Beta Kappa with highest honors from the University of Michigan with a Bachelor of Science in Cellular and Molecular Biology. He then went on to receive his medical degree from the University of Michigan and graduated with Alpha Omega Alpha status. During his medical studies he pursued a Sarnoff Cardiovascular Foundation Fellowship at the University of Kentucky under the guidance of Dr. Alan Daugherty investigating the pathological mechanisms of abdominal aortic aneurysm formation. Following medical school, he returned to the University of Michigan to complete his Integrated Vascular Surgery training. During his surgical training he spent two years as a National Institutes of Health Ruth L. Kirschstein Postdoctoral Fellow investigating the impact of epigenetic modifications to the immune system in diabetic wound healing and aortic aneurysm develop. Dr. Davis’s clinical interest and expertise is the surgical and endovascular management of aortic aneurysms, aorto-Iliac occlusive disease, cerebral vascular disease, and peripheral arterial disease.Clinical SpecializationDr. Davis’s clinical specialization is the surgical and endovascular management of aortic aneurysms, aorto-Iliac occlusive disease, cerebral vascular disease, and peripheral arterial disease.He is trained in complex open and endovascular work in all vascular beds. He performs a variety of procedures including TCAR, CEA, AAA repair, hemodialysis access, TEVAR, EVAR, pEVAR, FEVAR, Aortic Bypass Procedures, Mesenteric Revascularization, and Peripheral Angioplasty/Stenting/Open Bypass. He became a Registered Physician in Vascular Ultrasound Interpretation in 2019. Dr. Davis is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm, Peripheral Artery Disease, Idiopathic Edema, and Aneurysm Repair. Dr. Davis is board certified in Vascular Surgery.

Fred Morady is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Morady is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 84 other conditions, according to our data. His clinical expertise encompasses Arrhythmias, Ectopic Heartbeat, Atrial Fibrillation, Paroxysmal Supraventricular Tachycardia (PSVT), and Cardiac Ablation.

Dr. Hummel is the Director for Heart Failure with Preserved Ejection (HFpEF) program at the Frankel Cardiovascular Center. The HFpEF clinical program incorporates multi-domain assessment and management, with the goals of improving quality of life and long-term outcomes while uncovering and treating the underlying causes of this complex syndrome. The Michigan Medicine HFpEF program also offers access to groundbreaking clinical trials which incorporate interventions ranging from dietary support and medications to implantable cardiac devices for HFpEF. In addition to industry-sponsored trials, Dr. Hummel’s own research has been funded by the NHLBI, NIA, AHRQ, and the VA. This work aims to understand the impact of diet on HFpEF development and progression, and to facilitate healthy eating through technological innovation.As part of the American College of Cardiology’s Geriatric Cardiology leadership council, Dr. Hummel also studies the importance of geriatric domains, such as malnutrition, frailty, and polypharmacy, in heart failure assessment and management. Dr. Hummel is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Edema, Heart Transplant, and Cardiac Ablation. Dr. Hummel is board certified in Cardiovascular Disease and Advanced Heart Failure & Transplant Cardiology.

Dr. Palardy is a advanced heart failure, mechanical support and heart transplant specialist who finds great professional satisfaction in making a difference in the lives of her patients through all phases of their treatment. The multidisciplinary nature of her work allows her to be deeply involved in the many aspects of patient care, and at the same time to contribute to medical education through research. Her main research interests are regarding timing and selection of patients for mechanical circulatory support devices, refining advanced hear failure population prognosis and characteristics, as well as understanding early changes in myocardial function/strain in patients at risk cardiomyopathy such as neuromuscular disease.Dr. Palardy completed her cardiology training at the University of Montreal in 2007 in her hometown (Montreal, QC), and her Advanced Heart Failure fellowship at the Brigham and Women’s Hospital (Boston, MA) in 2008. She also pursued an additional year of training at the Brigham and Women's Hospital (2009) in echocardiography and advanced heart failure research. Following this, she served as the Advanced Heart Failure program director at CHUM Hospital at the University of Montreal and moved to University of Michigan in 2012 as an advanced heart failure cardiologist. She also involved in the echocardiography lab. Dr. Palardy is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Endoscopy. Dr. Palardy is board certified in Cardiovascular Disease and Advanced Heart Failure & Transplant Cardiology.

Abbas Bitar is a Clinical Lecturer in the Division of Cardiovascular Medicine. He received his undergraduate and medical degree from the American University of Beirut, Lebanon. He completed his residency training in Internal Medicine at Indiana University School of Medicine. He received his training in cardiovascular disease at the University of Louisville School of Medicine and completed his advanced heart failure and cardiac transplantation training at the University of Michigan. He joined the faculty in 2017. Dr. Bitar is actively engaged in clinical practice and clinical research in the areas of heart failure, heart transplantation and mechanical circulatory support. His research interest focuses on modeling outcomes of early post-operative complications for heart failure patients, being evaluated for advanced heart failure therapies, using a combination of risk stratification and by understanding the underlying pathophysiology. Dr. Bitar is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Cardiac Ablation.

Thomas Wakefield is a Vascular Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Wakefield is rated as an Advanced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Venous Insufficiency, Mesenteric Venous Thrombosis, Varicose Veins, Thrombectomy, and Angioplasty.

Katherine A. Gallagher, Professor of Surgery, Professor of Microbiology and Immunology and the Leland Ira Doan Research Professor of Vascular Surgery at U-M, is internationally known for her innovative translational research on epigenetic regulation of immune cells during normal and pathologic tissue repair and other cardiovascular disease processes. She is an expert in the molecular pathogenesis of wound repair and has contributed substantially to the understanding of epigenetics in immune cells associated with tissue repair, cardiovascular diseases, sepsis and most recently, COVID-19.She is, most notably, a member of the National Academy of Medicine, American Society of Clinical Investigation, American Surgical Association, Society of Clinical Surgery, a James IV International Scholar, a Distinguished Fellow of the Society of Vascular Surgery and a Taubman Scholar. Gallagher received a Bachelor of Science degree in physiology and neurobiology from the University of Maryland in 1998, graduating with Highest Honors. She was a Howard Hughes Fellow at the NIH for two years. She graduated summa cum laude from the University of Maryland School of Medicine in 2002. She pursued her general surgery training at the University of Maryland, followed by her vascular surgery training at Columbia University in New York. During her residency, she pursued a post-doctoral research fellowship at the University of Pennsylvania. She has been tenure track faculty at the University of Michigan since 2011. Dr. Gallagher is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Arterial Insufficiency, Peripheral Artery Disease, Arterial Embolism, and Abdominal Aortic Aneurysm (AAA). Dr. Gallagher is board certified in Vascular Surgery and Surgery.

Dr. Jeruss is a Professor of Surgery and the Director of the University of Michigan Breast Care Center. She also holds appointments in the Departments of Pathology and Biomedical Engineering at the University of Michigan. Dr. Jeruss received her undergraduate degree in neuroscience and history from Brandeis University and her medical degree from the University of Vermont. Dr. Jeruss completed her General Surgery residency training at Northwestern University Medical School and holds a PhD from Northwestern, having done her dissertation in the field of breast cancer biology. She completed her fellowship in Breast Surgical Oncology at M.D. Anderson Cancer Center in 2006, and returned to Northwestern as Associate Professor of Surgery in the Division of Breast Surgery before joining the University of Michigan faculty.Dr. Jeruss is board certified in General Surgery and is a member of several professional societies. Through her basic and clinical research program, Dr. Jeruss has been actively involved in the training of high school students, undergraduates, graduate students at the PhD and post-doctoral levels, medical students, and residents. She has published numerous manuscripts and book chapters, and has also received many awards for teaching and research. Dr. Jeruss is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Jeruss is board certified in Surgery.

Dr. Fine is an honors graduate of Harvard University and the U-M Medical School. He completed his internal medicine residency and served as chief medical resident at the U-M Medical Center. Dr. Fine was cited recently in The Best Doctors in America: Midwest Edition, 2017-2018. He enjoys piano and poetry composition, reading and music.Read Dr. Fine's 8 questions profile. Dr. Fine is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Colonoscopy, and Balloon Sinuplasty.

Michael Englesbe, MD, FACS is the Cyrenus G Darling Sr M.D. and Cyrenus G Darling Jr M.D. Professor of Surgery at the University of Michigan in the Section of Transplantation Surgery. Dr. Englesbe received his undergraduate degree at Yale University in New Haven, Connecticut in 1993. He went on to obtain his medical degree in 1997 from the Robert Wood Johnson Medical School and completed his general surgery residency at the University of Michigan Health System in 2004. From 2000 to 2002, Dr. Englesbe did a surgical research post-doctoral fellowship at the University of Washington Medical Center in Seattle, Washington. He does kidney and liver transplantation in adults and children. He has a specific expertise in portal hypertension in children and adults.Education Focus:Dr. Englesbe particularly enjoys working with undergraduate students, medical students, and young physician trainees. He serves as the Department of Surgery Vice Chair for Resident Mentorship and the University of Michigan Medical School Capstone Curriculum Director.Clinical Specialization:Dr. Englesbe specializes in kidney and liver transplantation in adults and children. He has a specific expertise in portal hypertension in children and adults. Dr. Englesbe is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Hernia, Liver Failure, End-Stage Renal Disease (ESRD), Liver Transplant, and Kidney Transplant. Dr. Englesbe is board certified in Surgery.

Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy. Dr. Dossett is board certified in Surgery and Complex General Surgical Oncology.

Dr. Allison Ruff graduated from the University of Florida before obtaining her medical degree at the University of Miami Miller School of Medicine. She completed her internal medicine training at the Cleveland Clinic in Cleveland, OH, where she also served as Chief Medical Resident. her clinical interests include primary care of medically complex adults, women's health, preventative medicine, and medical education. She lives in Ann Arbor with her husband and three children. Dr. Ruff is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. Her clinical expertise encompasses Type 2 Diabetes (T2D), Migraine, Maturity Onset Diabetes of the Young, and Osteopetrosis Autosomal Recessive Type 3.

Dr. Hadeed obtained her medical degree from New York University School of Medicine in Manhattan. She subsequently completed her Internal Medicine residency at the University of Michigan. Her clinical interests include women's health, care for the medically complex, medical education, and quality improvement in primary care. She enjoys biking, skiing and writing. Dr. Hadeed is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. Her clinical expertise encompasses Obesity, Seasonal Affective Disorder (SAD), Obesity in Children, and Glucocorticoid-Remediable Aldosteronism.